Posted by Michael Wonder on 24 Feb 2021
Bladder cancer drug shortage resolved with Health Canada approval
24 February 2021 - Verity-BCG bladder cancer treatment available for Canadian patients in the spring.
Verity Pharmaceuticals is pleased to announce that it has received a notice of compliance with conditions from Health Canada for the Verity-BCG (Bacillus Calmette-Guérin [BCG]: Strain Russian BCG-I).
This approval is welcome news for patients and health care providers who have endured a Canadian and global shortage of this important bladder cancer drug.
